Literature DB >> 14530957

From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care.

Andrea Liekweg1, Martina Westfeld, Ulrich Jaehde.   

Abstract

In recent years a paradigm shift towards a patient-focused rather than a disease-focused approach occurred in many health care systems. The pharmacy profession experienced an accordant development. The traditional drug-oriented services expanded towards patient-oriented services. In oncology, pharmacists established central services for compounding of cytotoxic drugs and offered therapeutic drug monitoring for critical substances. Pharmaceutical care concepts are now being introduced to optimize individual drug therapy. Pharmaceutical care aims at improving safety and therapeutic outcomes and consequently, the patient's quality of life. These objectives imply a close relationship to supportive care. To achieve this, a multidisciplinary approach seems to be beneficial.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530957     DOI: 10.1007/s00520-003-0539-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  11 in total

Review 1.  From the laboratory to pharmaceutical care research--Part I.

Authors:  M P Mobach
Journal:  Pharm World Sci       Date:  2001-12

2.  ASHP guidelines on a standardized method for pharmaceutical care. American Society of Health-System Pharmacists.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  1996-07-15       Impact factor: 2.637

Review 3.  Access to quality cancer care: consensus statement. American Federation of Clinical Oncologic Societies.

Authors: 
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

Review 4.  Critical analysis of the pharmaceutical care research literature.

Authors:  N R Kennie; B G Schuster; T R Einarson
Journal:  Ann Pharmacother       Date:  1998-01       Impact factor: 3.154

5.  Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach.

Authors:  Y Y Hon; W E Evans
Journal:  Clin Chem       Date:  1998-02       Impact factor: 8.327

6.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

7.  Opportunities and responsibilities in pharmaceutical care.

Authors:  C D Hepler; L M Strand
Journal:  Am J Hosp Pharm       Date:  1990-03

8.  Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study.

Authors:  G Dranitsaris; P Leung; D Warr
Journal:  Support Care Cancer       Date:  2001-11       Impact factor: 3.603

9.  Cost-reducing treatment algorithms for antineoplastic drug-induced nausea and vomiting.

Authors:  C M Berard; C D Mahoney
Journal:  Am J Health Syst Pharm       Date:  1995-09-01       Impact factor: 2.637

10.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

View more
  13 in total

Review 1.  The need for community pharmacists in oncology outpatient care: a systematic review.

Authors:  Johannes Thoma; Romána Zelkó; Balázs Hankó
Journal:  Int J Clin Pharm       Date:  2016-04-07

2.  [Not Available].

Authors:  Jean-François Bussières; Antoine Robelet; Roxane Therrien; Karine Touzin
Journal:  Can J Hosp Pharm       Date:  2010-03

3.  Implementation of a pharmacist-initiated pharmaceutical handover for oncology and haematology patients being transferred to critical care units.

Authors:  John Coutsouvelis; Carmela E Corallo; Michael J Dooley; Josephine Foo; Ann Whitfield
Journal:  Support Care Cancer       Date:  2009-08-07       Impact factor: 3.603

4.  Exploring autistic-like traits relating to empathic attitude and psychological distress in hospital pharmacists.

Authors:  Yuji Higuchi; Yosuke Uchitomi; Maiko Fujimori; Toshihiro Koyama; Hitomi Kataoka; Yoshihisa Kitamura; Toshiaki Sendo; Masatoshi Inagaki
Journal:  Int J Clin Pharm       Date:  2015-10-06

5.  Evaluation of clinical interventions made by pharmacists in chemotherapy preparation.

Authors:  Lea Knez; Raisa Laaksonen; Catherine Duggan
Journal:  Radiol Oncol       Date:  2010-09-22       Impact factor: 2.991

6.  Pharmaceutical care for patients with breast and ovarian cancer.

Authors:  Andrea Liekweg; Martina Westfeld; Michael Braun; Oliver Zivanovic; Tania Schink; Walther Kuhn; Ulrich Jaehde
Journal:  Support Care Cancer       Date:  2012-11       Impact factor: 3.603

7.  A cross-sectional study of psychological distress, burnout, and the associated risk factors in hospital pharmacists in Japan.

Authors:  Yuji Higuchi; Masatoshi Inagaki; Toshihiro Koyama; Yoshihisa Kitamura; Toshiaki Sendo; Maiko Fujimori; Yosuke Uchitomi; Norihito Yamada
Journal:  BMC Public Health       Date:  2016-07-08       Impact factor: 3.295

8.  Improving drug loading of mucosal solvent cast films using a combination of hydrophilic polymers with amoxicillin and paracetamol as model drugs.

Authors:  Joshua Boateng; Justine Mani; Farnoosh Kianfar
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

9.  Development and validation of the Japanese version of the Decisional Conflict Scale to investigate the value of pharmacists' information: a before and after study.

Authors:  Takashi Kawaguchi; Kanako Azuma; Takuhiro Yamaguchi; Hiroshi Soeda; Yusuke Sekine; Masayoshi Koinuma; Hironori Takeuchi; Takao Akashi; Sakae Unezaki
Journal:  BMC Med Inform Decis Mak       Date:  2013-04-17       Impact factor: 2.796

Review 10.  Minimising treatment-associated risks in systemic cancer therapy.

Authors:  Ulrich Jaehde; Andrea Liekweg; Sven Simons; Martina Westfeld
Journal:  Pharm World Sci       Date:  2007-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.